These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12039580)

  • 1. Preparation, characterization, molecular modeling and in vitro activity of paclitaxel-cyclodextrin complexes.
    Alcaro S; Ventura CA; Paolino D; Battaglia D; Ortuso F; Cattel L; Puglisi G; Fresta M
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1637-41. PubMed ID: 12039580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins.
    Sharma US; Balasubramanian SV; Straubinger RM
    J Pharm Sci; 1995 Oct; 84(10):1223-30. PubMed ID: 8801338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
    Baek JS; Cho CW
    J Pharm Pharmacol; 2013 Jan; 65(1):72-8. PubMed ID: 23215690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins.
    Hamada H; Ishihara K; Masuoka N; Mikuni K; Nakajima N
    J Biosci Bioeng; 2006 Oct; 102(4):369-71. PubMed ID: 17116587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo docking simulations of cyclomaltoheptaose and dimethyl cyclomaltoheptaose with paclitaxel.
    Kim H; Choi J; Kim HW; Jung S
    Carbohydr Res; 2002 Mar; 337(6):549-55. PubMed ID: 11890892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-Loaded β-Cyclodextrin-Modified Poly(Acrylic Acid) Nanoparticles through Multivalent Inclusion for Anticancer Therapy.
    Yuan S; Chen J; Sheng J; Hu Y; Jiang Z
    Macromol Biosci; 2016 Mar; 16(3):341-9. PubMed ID: 26611878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles.
    Agüeros M; Zabaleta V; Espuelas S; Campanero MA; Irache JM
    J Control Release; 2010 Jul; 145(1):2-8. PubMed ID: 20347897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of paclitaxel-loaded solid lipid nanoparticles in the presence of 2-hydoxypropyl-β-cyclodextrin.
    Baek JS; Kim BS; Puri A; Kumar K; Cho CW
    Arch Pharm Res; 2016 Jun; 39(6):785-93. PubMed ID: 27146520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation.
    Bhatt P; Lalani R; Vhora I; Patil S; Amrutiya J; Misra A; Mashru R
    Int J Pharm; 2018 Jan; 536(1):95-107. PubMed ID: 29175440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state.
    Acartürk F; Imai T; Saito H; Ishikawa M; Otagiri M
    J Pharm Pharmacol; 1993 Dec; 45(12):1028-32. PubMed ID: 7908969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docking experiments showing similar recognition patterns of paclitaxel when interacting with different macromolecular targets.
    Alcaro S; Battaglia D; Ortuso F
    Farmaco; 2003 Sep; 58(9):691-8. PubMed ID: 13679162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of paclitaxel-conjugated β-cyclodextrin polyrotaxane and its antitumor activity.
    Yu S; Zhang Y; Wang X; Zhen X; Zhang Z; Wu W; Jiang X
    Angew Chem Int Ed Engl; 2013 Jul; 52(28):7272-7. PubMed ID: 23740531
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of the antiinflammatory effect of ethyl 4-biphenylyl acetate in ointment by beta-cyclodextrin derivatives: increased absorption and localized activation of the prodrug in rats.
    Arima H; Adachi H; Irie T; Uekama K; Pitha J
    Pharm Res; 1990 Nov; 7(11):1152-6. PubMed ID: 2293214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles.
    Calleja P; Espuelas S; Vauthier C; Ponchel G; Irache JM
    J Pharm Sci; 2015 Sep; 104(9):2877-86. PubMed ID: 25600579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
    Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
    J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
    Arima H; Yunomae K; Hirayama F; Uekama K
    J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid lipid nanoparticles of paclitaxel strengthened by hydroxypropyl-β-cyclodextrin as an oral delivery system.
    Baek JS; So JW; Shin SC; Cho CW
    Int J Mol Med; 2012 Oct; 30(4):953-9. PubMed ID: 22859311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo toxicity and bioavailability of Taxol and a paclitaxel/beta-cyclodextrin formulation in a rat model during HIPEC.
    Bouquet W; Ceelen W; Adriaens E; Almeida A; Quinten T; De Vos F; Pattyn P; Peeters M; Remon JP; Vervaet C
    Ann Surg Oncol; 2010 Sep; 17(9):2510-7. PubMed ID: 20339948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue.
    Uekama K; Hieda Y; Hirayama F; Arima H; Sudoh M; Yagi A; Terashima H
    Pharm Res; 2001 Nov; 18(11):1578-85. PubMed ID: 11758766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cytotoxicity of paclitaxel/beta-cyclodextrin complexes for HIPEC.
    Bouquet W; Boterberg T; Ceelen W; Pattyn P; Peeters M; Bracke M; Remon JP; Vervaet C
    Int J Pharm; 2009 Feb; 367(1-2):148-54. PubMed ID: 18938234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.